Disclaimer: The information provided by Stockify is for educational and informational purposes only and does not constitute investment advice. Stockify is not a SEBI-registered broker, investment advisor, or research analyst. Investments in unlisted shares involve risks. Please consult your financial advisor and conduct your own due diligence before making any investment decision.
Stay ahead of the curve with in-depth articles, IPO alerts, and financial guides for the unlisted market.
Thyrocare sells 100% of Nueclear Healthcare for Rs. 141.4 Cr, exits radiology to focus on pathology. Know deal structure, financials, and investor impact.
MSEI unlisted shares gained over 100% YTD 2026, from Rs. 3.25 to Rs. 6.70-6.75. CSE unlisted shares rose from around Rs. 1,500 (Jan-Feb 2026) to around Rs. 2,600 now.
Analyze the business, objectives, risks, and strengths of Apollo Green Energy along with its IPO plans.
Care Health Insurance, Religare's key subsidiary, allots Rs.100 crore subordinated NCDs at 10% coupon. Check tenor, listing date, and rating details.
Garuda Aerospace's FY26 Annual Report shows 67% revenue growth and 41% profit growth, but negative operating cash flow tell a very different story.
NSE's Rs.22,561 crore IPO is open till Sept 21, 2026. Here are the 4 things that truly matter, revenue mix, regulation, competition & valuation.
PharmEasy's unlisted share price rises 40% after API Holdings reports better profits, cash flow, and debt reduction, and Thyrocare announces changes. Read this blog for a detailed analysis.
1.jpg)
NSE’s expected IPO to reshape India’s unlisted-share market. Why NSE shares are a major attraction, what may change after listing, and the risks.
MSEI share price jumped from Rs 5.75 to Rs 7.46 in September 2026. Explore the impact of cash market integration, DEMAT bonds, and rising trading activity.
The NSE IPO 2026 could value the exchange at up to Rs. 4.42 lakh crore. See how NSE compares with Nasdaq, BSE, and other global exchanges.
MSE may emerge as an additional cash market trading option for retail investors. Learn how it works, why liquidity matters and what to watch before trading
API Holdings' 7th AGM on Sep 30, 2026 covers new board appointments, CFO, and expanded healthcare business objects for PharmEasy's parent firm.
.jpg.jpeg)
Capgemini India FY26 revenue rose to Rs.1,34,143 million, while profit attributable to equity shareholders increased to Rs.41,046 million.